UC Irvine in clinical trial to test drug’s potential to treat COVID-19
Daily Pilot, March 23, 2020
Search: “clinical trial”
UCI researchers will test former Ebola drug as part of coronavirus clinical trial
Orange County Register, March 23, 2020
UC Irvine in clinical trial to test antiviral treatment for COVID-19
KTLA5, March 23, 2020 (Video)
UC Irvine Participating In Clinical Trial For Coronavirus Treatment
CBS2, March 23, 2020 (Video)
Stem cell therapy for retinitis pigmentosa found safe, well-tolerated in first-stage clinical trial
Sue & Bill Gross Stem Cell Research Center researchers have reported that a therapy they created to cure retinitis pigmentosa is safe and well-tolerated, with no immunological issues, by the first group of patients enrolled in an ongoing phase I/II clinical trial. Led by the regenerative medicine company jCyte, the trial has successfully undergone four […]
UCI-led team begins first clinical trial of stem cell-based retinitis pigmentosa treatment
Participants are sought for safety study on the use of retinal progenitors in the eye
FDA greenlights UCI clinical trial of treatment for blinding disease
A first-of-its-kind stem cell-based treatment for retinitis pigmentosa developed by UC Irvine’s Dr. Henry Klassen, Dr. Jing Yang and colleagues has received consent from the U.S. Food & Drug Administration for use in a clinical trial.
UC Irvine opens clinical trial of novel treatment for brain cancer
Experiemental vaccines hold promise to slow the return of glioblastoma multiforme. UC Irvine begins enrolling patients in DCVax trial.
Spinal cord injury patients report regained sensation in human neural stem cells clinical trial
Swiss doctors with the world’s first clinical trial using human neural stem cells to treat chronic thoracic spinal cord injury report that two patients have regained some ability to feel touch and heat.
UCI-created stem cell treatment passes safety phase of clinical trial
Doctors with the Balgrist University Hospital in Zurich report that the surgery, immunosuppression and cell transplants have been well tolerated.